T1	Participants 361 572	Patients with T18N0M0 (A2) or T2N0M0 (B) disease after lymphangiogram (LAG) or staging laparotomy (SL) were randomized between prophylactic radiation to the pelvic lymph nodes and prostatic bed vs. prostatic bed
T2	Participants 718 747	A total of 449 eligible males
T3	Participants 876 926	117 (26%) patients had SL, while 332 (74%) had LAG
